{"lastClose": 3.9200000762939453, "len": 993, "date": "2023-03-14", "alpha_1": -0.7923582255644591, "beta_1": 0.8520572846432718, "drawup_1": 0.7155424508464454, "natr_1": 20.957623755614577, "sup_1": -0.7721088220224804, "res_1": 0.8154761875799493, "bullPattern_1": ["HAMMER"], "bearPattern_1": [], "rsi_1": 34.725841558777546, "adx_1": 16.912805007413457, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.6502097115786731, "stratHoldAlpha_1": 250.45228171717002, "stratHoldDrawdown_1": -0.7410786446934408, "alpha_3mo": -0.5184447561151149, "beta_3mo": 1.438613758630735, "drawup_3mo": 0.20805376931257258, "natr_3mo": 20.957623755614577, "sup_3mo": -0.039966048870617776, "res_3mo": 0.0731292210832733, "bullPattern_3mo": [], "bearPattern_3mo": ["HANGINGMAN"], "rsi_3mo": 23.684211351865155, "adx_3mo": 46.95514153867335, "drawdown_3mo": -0.28518521723596757, "stratHoldSharpe_3mo": -1.960418505471001, "stratHoldAlpha_3mo": 250.04315208056863, "stratHoldDrawdown_3mo": -0.2575729710377658, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "NGM Biopharmaceuticals Inc.", "Sector": "Health Care", "Market Cap": 320366363, "IPO Year": 2019.0, "alpha%_1": 0.007986246642777393, "beta%_1": 0.402940522983183, "drawup%_1": 0.6703667585586285, "natr%_1": 0.9999999999756973, "drawdown%_1": 0.013144951858512567, "stratHoldSharpe%_1": 0.1716767515899718, "stratHoldAlpha%_1": 0.014925544824846428, "stratHoldDrawdown%_1": 0.013451345492753721, "alpha%_3mo": 0.13558459009531804, "beta%_3mo": 0.7871123932084516, "drawup%_3mo": 0.4047855776566745, "natr%_3mo": 0.9999999999572272, "drawdown%_3mo": 0.12786990589156344, "stratHoldSharpe%_3mo": 0.10373025783875328, "stratHoldAlpha%_3mo": 0.039508522800027604, "stratHoldDrawdown%_3mo": 0.13634727603221292}